OLMA today
$7.73+$0.21 (+2.79%)close Nov 13, 2026Trend
DailyDowntrend (confirmed)
4 hourLeaning Bearish
1 hourAscending Triangle
15 minStrong Bullish
5 minStrong Bullish
Daily trend turns up above $7.61
Key levels
Resistance$8.83
Resistance$8.25
Support$7.60
Support$6.71
Latest news & SEC filings
EarningsOlema Oncology Posts Q3 2026 Results
EarningsOlema Pharmaceuticals posts wider Q3 loss than expected
All OLMA news →About Olema Pharmaceuticals
Olema Pharmaceuticals develops experimental medicines for breast cancer and other tumors. Its main drug candidate, palazestrant, is an oral treatment being tested alone and with other agents in patients whose tumors are ER-positive and HER2-negative. A second candidate, OP-3136, targets KAT6 in breast and other solid cancers. The company operates in the United States and uses outside manufacturers for its drug supply.
Based on the company's 10-K filed Mar 16, 2026.
Nasdaq · Healthcare
Olema Pharmaceuticals, Inc. (OLMA)
What Is the Price Target for OLMA?
SEPT Low Target
$30.00
SEPT Mid Target
$36.00
SEPT High Target
$59.00
Analyst Consensus
$36.00
Is OLMA a Buy or Sell Right Now?
Thesis
- •SEC filings signal active product innovation — 1 new product/expansion keywords detected in 10-K. R&D investment rising.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for OLMA.
Start Free Trial →Is OLMA Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$29.66
12
Moat Score
NONE
1/9
Piotroski Score
5.3
Altman Z-Score
What Is Smart Money Doing with OLMA?
Insider Signal
SELLING
0 buys / 9 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →OLMA Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
15%
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
Dark Pool Trades for OLMA
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for OLMA, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 19:00:21 | $7.74 | 2,300 | $$18K | MIDPOINT |
| 18:55:43 | $7.74 | 1,500 | $$12K | MIDPOINT |
| 18:34:40 | $7.80 | 1,025 | $$8K | BUY |
| 18:10:05 | $7.75 | 1,500 | $$12K | BUY |
| 18:02:43 | $7.68 | 1,000 | $$8K | SELL |
5 dark pool trades shown · $$57K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for OLMA
PREVIEWSEPT Investing provides real-time options flow tracking for OLMA, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $7 | Jan 15 | 63 | $$640 | 4 | SWEEP |
| CALL | $7 | Jan 15 | 63 | $$160 | 1 | SWEEP |
| CALL | $7 | Jan 15 | 63 | $$310 | 2 | SWEEP |
| CALL | $7 | Jan 15 | 63 | $$145 | 1 | SWEEP |
| CALL | $7 | Jan 15 | 63 | $$170 | 1 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Olema Pharmaceuticals, Inc. (OLMA) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (3 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →OLMA — frequently asked questions
What is OLMA stock price today?
Olema Pharmaceuticals, Inc. (OLMA) is at $7.73, up 2.79% (+$0.21) at the Nov 13, 2026 close.
Why is OLMA stock moving today?
Latest OLMA news — Nov 10, 2026: Olema Oncology Posts Q3 2026 Results · Nov 10, 2026: Olema Pharmaceuticals posts wider Q3 loss than expected
Why did OLMA stock move on Nov 10, 2026?
Olema Pharmaceuticals reported its third-quarter 2026 results, posting a loss of 73 cents per share that came in wider than the 63 cents analysts had expected. The stock closed essentially flat at $7.27, down 0.14%, after trading in a wide range between $7.00 and $7.59 on volume of about 920,000 shares.
What is the OLMA price target?
The average analyst price target for OLMA is $36.00, ranging from $30 to $59, based on 5 analysts. Latest: Stifel maintains on Sep 14, 2026.
What do analysts rate OLMA?
Analyst ratings for OLMA: 0 Buy, 6 Hold, 0 Sell — consensus Hold.
Did OLMA beat earnings?
OLMA last reported on Nov 10, 2026: EPS -$0.73 vs -$0.63 expected — a miss of 15.9%.
Does OLMA pay a dividend?
OLMA does not currently pay a dividend.
What are OLMA support and resistance levels?
Support: $7.60, $6.71, $5.97. Resistance: $8.25, $8.83, $9.44.
What are insiders doing with OLMA?
Insider activity: SELLING, 0 buys and 9 sells in the last 90 days.
What is the latest news on OLMA?
Nov 10, 2026: Olema Oncology Posts Q3 2026 Results · Nov 10, 2026: Olema Pharmaceuticals posts wider Q3 loss than expected